<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151257">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01789489</url>
  </required_header>
  <id_info>
    <org_study_id>2010/12</org_study_id>
    <nct_id>NCT01789489</nct_id>
  </id_info>
  <brief_title>3D Ultrasound - Based Hysteroscopy Versus Virtual Hysteroscopy</brief_title>
  <official_title>Contribution of 3D Sonohysterography and Virtual Hysteroscopy in Exploration of the Uterine Cavity in Comparison to the Diagnostic Hysteroscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France : Agence Française de Sécurité Sanitaire des Produits de Santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To prove that the 3 dimensional sonohysterography is, at least, as effective as the
      diagnostic hysteroscopy in examining the uterine cavity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Polyps, fibrosis, atrophy, hypertrophy and other uterine pathology detected by 3D sonohysterography (Accuracy of uterine cavity exploration by 3D sonohysterography)</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">69</enrollment>
  <condition>Endometrial or Uterine Pathology</condition>
  <arm_group>
    <arm_group_label>3 dimensional sonohysterography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard hysteroscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medison Accuvix V20, sonde 3D5-9EK (Endovaginal 3 dimensional echography)</intervention_name>
    <arm_group_label>3 dimensional sonohysterography</arm_group_label>
    <arm_group_label>Standard hysteroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Diagnostic hysteroscopy prescribed either for a case of infertility or in case of doubt
        of endometrial / uterine pathology suspected by ultrasound  or  hysterography.

        Exclusion Criteria:

          -  Current Pregnancy.

          -  Genital infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphanie FAY, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital FOCH  40, rue Worth 92150 Suresnes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphanie FAY, MD</last_name>
    <email>s.fay@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital FOCH</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie FAY, MD</last_name>
      <email>s.fay@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Stéphanie FAY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 8, 2013</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
